A handful of companies are seeking to become the first China-headquartered businesses to go public in the US since July, in a test of regulators’ willingness to accept new listings after clampdowns on both sides of the Pacific.
Six China and Hong Kong-based groups filed new or updated documents with the US Securities and Exchange Commission for an initial public offering on the Nasdaq exchange in January. They were followed last week by Meihua International Medical Technologies, a producer of disposable medical devices, which set a target offering price after submitting its initial filing almost six months ago.
Although each deal is expected to be small in size, lawyers, exchange officials and China experts will be watching them closely for signs that there is still a future for the once-thriving market for Chinese listings.